Williams Jones & Associates’s Haemonetics HAE Stock Holding History

Williams Jones & Associates’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$686K	Sell	5,700 -3,850	-40%	-$379K	0.01%	239
2019 Q1	$835K	Buy	9,550 +7,300	+324%	+$664K	0.02%	217
2018 Q4	$225K	Hold	2,250	–	–	0.01%	344
2018 Q3	$258K	Buy	+2,250	New	+$233K	0.01%	379
2018 Q2	–	Sell	-4,050	Closed	-$296K	–	456
2018 Q1	$296K	Buy	+4,050	New	+$278K	0.01%	351

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Williams Jones & Associates's HAE Position: Q2 2019 in Review

Williams Jones & Associates reduced its Haemonetics (HAE) stake by 40% in Q2 2019, selling an estimated $379K and leaving 5,700 shares worth $686K. The position accounts for 0.01% of the portfolio, ranked #239.

Williams Jones & Associates first reported a position in HAE in Q1 2018 and has held it in 5 quarters since. The position peaked at $835K in Q1 2019. 256 funds tracked by Wall St. Rank hold HAE as of Q2 2019.

Williams Jones & Associates held 5,700 shares of Haemonetics worth $686K as of Q2 2019.
Williams Jones & Associates sold 3,850 Haemonetics shares in Q2 2019, an estimated $379K.
Haemonetics made up 0.01% of Williams Jones & Associates's portfolio in Q2 2019, its #239 holding.
Williams Jones & Associates first reported a position in Haemonetics in Q1 2018 and has held it in 5 quarters since.
Williams Jones & Associates's Haemonetics position peaked at $835K in Q1 2019.
256 funds tracked by Wall St. Rank held Haemonetics as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.